Skip to main content

About Takeda

Robbie Woodman, Ph.D.

Senior Partner

Dr. Rob Woodman joined TVI in March 2018 as Senior Partner, and is based in London, UK.

Prior to joining TVI, Rob was Director of Healthcare Investments at Touchstone Innovations (formerly Imperial Innovations) in London. He has led the formation of and fundraising for a number of UK biotech companies, such as Mission Therapeutics, Crescendo Biologics, Storm Therapeutics, and Enterprise Therapeutics.

Rob joined Touchstone Innovations in 2012 and was previously a Principal in the life science team at Sofinnova Partners, a leading European venture capital firm. While at Sofinnova, Rob was actively involved in numerous investments throughout Europe. Rob's experience also includes technology transfer with Cancer Research Technology (CRUK) and pharmaceutical consultancy with IMS Health.

Rob holds an MSc in Biochemistry from the University of Oxford and a Ph.D. in Oncology from the University of Cambridge.